Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT04982263
NCT04982263CompletedNot Applicable

Blood Coagulation Abnormalities in COVID-19 Patients and Correlation With Severity

Sohag University1 site in 1 country125 target enrollmentStarted: February 1, 2021Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
125
Locations
1
Primary Endpoint
correlation of disease severity with results of laboratory test
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

The role of the coagulation parameters in predicting the severity of COVID-19 disease will be assessed

Detailed Description

In COVID-19 patients the coagulation parameters Prothrombin concentration (PC), Activated Partial Thromboplastin Time (aPTT), D Dimer, Antithrombin III (ATIII) and Fibrinogen are measured and correlation with disease severity is to be investigated

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •● Confirmed cases with COVID 19

Exclusion Criteria

  • •● Known history of blood coagulopathy disorder

Outcomes

Primary Outcomes

correlation of disease severity with results of laboratory test

Time Frame: Baseline results of coagulation profile and baseline disease severity assessment

The results of blood coagulation profile will be correlated with degree of severity of illness

Secondary Outcomes

  • Agreement of abnormalities in coagulation profile with measured inflammatory markers(baseline measurement of inflammatory markers)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Hend Mohammed Abdelraheem Esmaeel

assistant professor

Sohag University

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
COVID-19 Associated Coagulopathy in EgyptCoagulopathy
NCT04507230Assiut University106
Completed
Not Applicable
Role of Hematological Parameters in the Stratification of COVID-19 Disease SeverityCovid19
NCT04670328FMH College of Medicine and Dentistry101
Completed
Not Applicable
Platelet Aggregation in COVID-19 PatientsCOVID-19
NCT06097429Mansoura University75
Unknown
Phase 2
Hemostasis in COVID-19: an Adaptive Clinical TrialCOVID-19
NCT04466670University of Sao Paulo General Hospital379
Unknown
Not Applicable
Hemostatic Profile in Patients Affected by COVID-19Covid19Thrombosis
NCT04595110ANNA FALANGA400